Tuesday, July 22, 2025
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PRESENTING FACULTY
 |
Dr. Amy Armstrong, MD Associate Professor of Pediatrics Division of Pediatric Hematology/Oncology Washington University School of Medicine St. Louis Children’s Hospital, St. Louis, MO |
PROGRAM OVERVIEW
This live virtual TeleECHO educational series focuses on neurofibromatosis 1 (NF1), a complex and heterogeneous genetic disorder with associated morbidities that significantly impair health-related quality of life. Engage with key experts in the field to improve knowledge regarding the pathophysiology of NF1 plexiform neurofibromas (NF1-PN) that have guided the investigation of targeted therapies which are revolutionizing the therapeutic landscape for both children and adults with symptomatic inoperable NF1-PN. Delve into in-depth discussions on case studies that bring real-world practical advice and involvement of comprehensive multidisciplinary care teams into the optimal care for patients to improve both their quality of life and disease outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of academic and community medical oncologists, neuro-oncologists, neurologists, surgical oncologists, neurosurgeons, advanced practice providers, and other healthcare providers who care for patients with NF1-PN.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize key signs and symptoms of NF1-PN in adults
- Interpret clinical trial data on available and emerging therapeutic options for the treatment of NF1-PN
- Incorporate clinical practice recommendations for the use of systemic therapies for NF1-PN and mitigation of potential adverse events
- Cultivate comprehensive multidisciplinary care approaches for patients with NF1-PN
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-FDA-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
